Stock
IMTX
| Ownership Count: | 201 |
| Ownership Count: | 201 |
| Manager Name | % of Portfolio | Recent Activity | Share | Value |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 0.05% |
Added 43.70%
|
10,604,777 | $75,400,000.0 |
| PERCEPTIVE ADVISORS LLC | 2.17% |
Added 16.04%
|
9,383,456 | $66,716,000.0 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.01% |
Added 9.97%
|
8,722,293 | $62,015,000.0 |
| BAKER BROS. ADVISORS LP | 0.57% |
Added 12.92%
|
7,275,830 | $51,731,000.0 |
| RTW INVESTMENTS, LP | 0.75% |
Reduced 34.59%
|
6,540,540 | $46,503,000.0 |
| Vestal Point Capital, LP | 2.96% |
Added 67.33%
|
6,275,000 | $44,615,000.0 |
| Paradigm Biocapital Advisors LP | 1.42% |
Added 38.66%
|
5,414,409 | $38,496,000.0 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1.54% |
Added 435.12%
|
5,065,277 | $36,014,000.0 |
| BRAIDWELL LP | 1.24% |
Added 112.68%
|
3,503,965 | $24,913,000.0 |
| ORBIMED ADVISORS LLC | 0.55% |
Added 53.88%
|
3,087,462 | $21,951,000.0 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.0% |
Reduced 29.56%
|
2,461,592 | $17,502,000.0 |
| GOLDMAN SACHS GROUP INC | 0.0% |
Added 1983.23%
|
2,380,406 | $16,924,000.0 |
| Frazier Life Sciences Management, L.P. | 0.74% |
Added 58.55%
|
2,147,911 | $15,271,000.0 |
| MORGAN STANLEY | 0.0% |
Added 1276.58%
|
2,079,458 | $14,784,000.0 |
| Woodline Partners LP | 0.11% |
Reduced 18.69%
|
2,034,224 | $14,463,000.0 |